Hosted on MSN23d
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity," said Patrik Jonsson, president of Lilly USA.
MedCity News24d
Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea
and president of Lilly Cardiometabolic Health and Lilly USA, said in a prepared statement. “Nearly half of clinical trial patients saw such improvements that they no longer had symptoms ...
UPI25d
FDA approves weight-loss drug Zepbound to treat sleep apnea
president of Lilly Cardiometabolic Health and Lilly USA. "Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity.
Hosted on MSN25d
FDA approves first-ever medication for obstructive sleep apnea
executive vice president and president of Lilly Cardiometabolic Health and Lilly USA. "Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term ...
Lilly Pulitzer gets rights to archive prints by artist credited with creating 'Lilly Look'
The deal will open the door for the company to tap into an archive of more than 2,000 designs by Key West Hand Print Fabrics Co. and Suzie Zuzek.
The Hill25d
FDA approves weight-loss drug to treat sleep apnea
On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use ... of Lilly Cardiometabolic Health and Lilly USA Patrik Jonsson said in a statement. “Nearly half of clinical ...